XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.24.3

SEGMENT REPORTING (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Segment Reporting [Abstract] |
SCHEDULE OF SEGMENTS | The following table presents certain information regarding the Company’s segments as of and for the three months ended September 30, 2024 and 2023 (in thousands): SCHEDULE OF SEGMENTS 2024
|  | CVD Equipment |  |  | SDC |  |  | CVD Materials |  |  | Eliminations |  |  | Corporate |  |  | Consolidated |
Assets |  | $ | 27,270 |  |  | $ | 3,805 |  |  | $ | 836 |  |  | $ | (65 | ) |  | $ | - |  |  | $ | 31,846 |
Revenue |  | $ | 5,681 |  |  | $ | 2,005 |  |  | $ | 661 |  |  | $ | (153 | ) |  | $ | - |  |  | $ | 8,194 |
Operating (loss) income |  |  | *(736 | ) |  |  | 538 |  |  |  | **1,104 |  |  |  | 18 |  |  |  | (847 | ) |  |  | 77 |
Pretax (loss) income |  |  | *(741 | ) |  |  | 538 |  |  |  | **1,104 |  |  |  | 18 |  |  |  | (711 | ) |  |  | 208 |
Depreciation and amortization |  | $ | 157 |  |  | $ | 12 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 169 |
Purchase of property, plant & equipment |  | $ | 30 |  |  | $ | 7 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 37 |
2023
|  | CVD Equipment |  |  | SDC |  |  | CVD Materials |  |  | Eliminations |  |  | Corporate |  |  | Consolidated |
Assets |  | $ | 32,915 |  |  | $ | 4,237 |  |  | $ | 177 |  |  | $ | (102 | ) |  | $ | - |  |  | $ | 37,227 |
Revenue |  | $ | 4,795 |  |  | $ | 1,572 |  |  | $ | 90 |  |  | $ | (223 | ) |  | $ | - |  |  | $ | 6,234 |
Operating (loss) income |  |  | (323 | ) |  |  | 436 |  |  |  | (35 | ) |  |  | (76 | ) |  |  | (992 | ) |  |  | (990 | )
Pretax (loss) income |  |  | (262 | ) |  |  | 434 |  |  |  | (31 | ) |  |  | (76 | ) |  |  | (818 | ) |  |  | (753 | )
Depreciation and amortization |  | $ | 137 |  |  | $ | 12 |  |  | $ | 4 |  |  | $ | - |  |  | $ | - |  |  | $ | 153 |
Purchase of property, plant & equipment |  | $ | 83 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 83 |
* | Includes a $1.0 million non-cash charge to reduce certain inventory to net realizable value – see Note 5.
** | Includes gain on sale of equipment of $0.6 million related to MesoScribe – see Note 11.
CVD EQUIPMENT CORPORATION AND SUBSIDIARIES Notes to Condensed Consolidated Financial Statements (Unaudited) NOTE 10: SEGMENT REPORTING (continued) The following table presents certain information regarding the Company’s segments as of and for the nine months ended September 30, 2024 and 2023 (in thousands): 2024
|  | CVD Equipment |  |  | SDC |  |  | CVD Materials |  |  | Eliminations |  |  | Corporate |  |  | Consolidated |
Revenue |  | $ | 12,737 |  |  | $ | 6,252 |  |  | $ | 775 |  |  | $ | (302 | ) |  | $ | - |  |  | $ | 19,462 |
Operating (loss) income |  |  | *(2,884 | ) |  |  | 1,884 |  |  |  | **1,034 |  |  |  | 28 |  |  |  | (2,513 | ) |  |  | (2,451 | )
Pretax (loss) Income |  |  | *(2,894 | ) |  |  | 1,884 |  |  |  | **1,034 |  |  |  | 28 |  |  |  | (2,075 | ) |  |  | (2,025 | )
Depreciation and amortization |  | $ | 441 |  |  | $ | 35 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 476 |
Purchase of property, plant & equipment |  | $ | 209 |  |  | $ | 10 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 219 |
2023
|  | CVD Equipment |  |  | SDC |  |  | CVD Materials |  |  | Eliminations |  |  | Corporate |  |  | Consolidated |
Revenue |  | $ | 13,774 |  |  | $ | 5,679 |  |  | $ | 1,009 |  |  | $ | (554 | ) |  | $ | - |  |  | $ | 19,998 |
Operating (loss) income |  |  | (581 | ) |  |  | 1,430 |  |  |  | ***(178 | ) |  |  | (104 | ) |  |  | (2,977 | ) |  |  | (2,410 | )
Pretax (loss) Income |  |  | (518 | ) |  |  | 1,430 |  |  |  | ***(126 | ) |  |  | (104 | ) |  |  | (2,577 | ) |  |  | (1,895 | )
Depreciation and amortization |  | $ | 404 |  |  | $ | 36 |  |  | $ | 105 |  |  | $ | - |  |  | $ | - |  |  | $ | 545 |
Purchase of property, plant & equipment |  | $ | 298 |  |  | $ | 10 |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 308 |
* | Includes a $1.0 million non-cash charge to reduce certain inventory to net realizable value – see Note 5.
** | Includes gain on sale of equipment of $0.6 million related to MesoScribe – see Note 11.
*** | Includes loss on sale of Tantaline of $0.2 million and impairment charge related to MesoScribe fixed assets of $0.1 million – see Note 11.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration